002821 Asymchem Laboratories(Tianjin)Co.,Ltd.
Noon Closed 01-21 11:30:00
104.33
+1.13
+1.09%
High105.78Low102.52Vol2.63M
Open102.96D1 Closing103.20Amplitude3.16%
Mkt Cap37.66BTradable Cap33.07BTotal Shares361.00M
T/O275.00MT/O Rate0.83%Tradable Shares317.00M
P/B2.14ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Schroders PLC Reduces Stake in Asymchem by 167,700 Shares at HK$83.63 Per Share
Stock News  ·  01-13
Schroders PLC Reduces Stake in Asymchem by 167,700 Shares at HK$83.63 Per Share
Schroders PLC Reduces Stake in Asymchem, Selling 260,500 Shares at HK$82.71 Per Share
Deep News  ·  01-11
Schroders PLC Reduces Stake in Asymchem, Selling 260,500 Shares at HK$82.71 Per Share
Schroders PLC Reduces Stake in Asymchem by 260,500 Shares at HK$82.71 Per Share
Stock News  ·  01-09
Schroders PLC Reduces Stake in Asymchem by 260,500 Shares at HK$82.71 Per Share
471 Shenzhen Market Companies Lead "Quality and Return Enhancement" Initiative, Dividend Payout Ratio Rises Nearly 11 Percentage Points in 2 Years
Deep News  ·  2025-12-27
471 Shenzhen Market Companies Lead "Quality and Return Enhancement" Initiative, Dividend Payout Ratio Rises Nearly 11 Percentage Points in 2 Years
Asymchem Laboratories Cuts Buyback Price Under 2025 Share Scheme; Shares
MT Newswires Live  ·  2025-12-22
Asymchem Laboratories Cuts Buyback Price Under 2025 Share Scheme; Shares
Asymchem (06821) to Repurchase and Cancel 33,000 Restricted A Shares
Stock News  ·  2025-12-19
Asymchem (06821) to Repurchase and Cancel 33,000 Restricted A Shares
Asymchem Laboratories Announces Repurchase and Cancellation of Restricted A Shares
Reuters  ·  2025-12-19
Asymchem Laboratories Announces Repurchase and Cancellation of Restricted A Shares
Pharmaceutical Stocks Rebound Sharply This Morning with Asymchem and Wuxi Biologics Both Rising Over 6%
Deep News  ·  2025-12-19
Pharmaceutical Stocks Rebound Sharply This Morning with Asymchem and Wuxi Biologics Both Rising Over 6%
AsymBio Launches Commercial Operations at Fengxian Base
Reuters  ·  2025-12-08
AsymBio Launches Commercial Operations at Fengxian Base
Asymchem (06821) Rises Nearly 3% Before Noon as Shanghai Fengxian Base Officially Commences Operations, Focusing on NDCs and Other Fields
Stock News  ·  2025-12-08
Asymchem (06821) Rises Nearly 3% Before Noon as Shanghai Fengxian Base Officially Commences Operations, Focusing on NDCs and Other Fields
Asymchem Laboratories (06821) Grants 291,400 Restricted A Shares
Stock News  ·  2025-11-27
Asymchem Laboratories (06821) Grants 291,400 Restricted A Shares
Asymchem Laboratories Tianjin Files Next Day Disclosure Return to HKEX for Share Capital Increase with 331,597,760 New Shares Issued
Reuters  ·  2025-11-27
Asymchem Laboratories Tianjin Files Next Day Disclosure Return to HKEX for Share Capital Increase with 331,597,760 New Shares Issued
JPMorgan Reduces Stake in Asymchem (06821) by 70,700 Shares at HK$84.7 per Share
Stock News  ·  2025-11-18
JPMorgan Reduces Stake in Asymchem (06821) by 70,700 Shares at HK$84.7 per Share
JPMorgan Increases Stake in Asymchem (06821) by 61,900 Shares at Average Price of HK$83.89 per Share
Stock News  ·  2025-11-13
JPMorgan Increases Stake in Asymchem (06821) by 61,900 Shares at Average Price of HK$83.89 per Share
Norges Bank Increases Stake in Asymchem (06821) by 65,200 Shares at HK$84.39 per Share
Stock News  ·  2025-11-11
Norges Bank Increases Stake in Asymchem (06821) by 65,200 Shares at HK$84.39 per Share
JPMorgan Reduces Stake in Asymchem by 202,000 Shares at HK$83.43 per Share
Deep News  ·  2025-11-10
JPMorgan Reduces Stake in Asymchem by 202,000 Shares at HK$83.43 per Share
JPMorgan Reduces Stake in Asymchem (06821) by 202,000 Shares at HK$83.43 per Share
Stock News  ·  2025-11-07
JPMorgan Reduces Stake in Asymchem (06821) by 202,000 Shares at HK$83.43 per Share
Asymchem (06821) Rises Over 3% as Q1-Q3 Net Profit Grows 12.66% YoY, Emerging Businesses Poised as Core Growth Driver
Stock News  ·  2025-11-07
Asymchem (06821) Rises Over 3% as Q1-Q3 Net Profit Grows 12.66% YoY, Emerging Businesses Poised as Core Growth Driver
Norges Bank Increases Stake in Asymchem (06821) by 62,300 Shares at HK$84.51 per Share
Stock News  ·  2025-11-06
Norges Bank Increases Stake in Asymchem (06821) by 62,300 Shares at HK$84.51 per Share
Norges Bank Increases Stake in Asymchem (06821) by 213,700 Shares at HK$86.6 per Share
Stock News  ·  2025-11-03
Norges Bank Increases Stake in Asymchem (06821) by 213,700 Shares at HK$86.6 per Share

Introduction

Company Name.
凯莱英医药集团(天津)股份有限公司
Industry:
医药制造业
Listing Date:
2016-11-18
Main Business:
　　凯莱英医药集团(天津)股份有限公司的主营业务是为国内外制药公司、生物技术公司提供药品全生命周期的一站式服务。公司的主要产品是临床阶段CDMO解决方案、商业化阶段CDMO解决方案、新兴服务。截至报告期末公司共有国内外已授权专利538项，其中国内专利423项，国外专利115项，其中183项在合成生物领域，204项在连续反应技术领域。
Issue price:
30.53